Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18040259 | 1.00 | BTN3A1 (0.41) | BTN3A1MEN1KMT2AHSD17B10TDP1 | |
| SCHEMBL662434 | 0.97 | BTN3A1 (0.43) | BTN3A1MEN1KMT2AHSD17B10TDP1 | |
| SCHEMBL28723527 | 0.89 | BTN3A1 (0.36) | BTN3A1THRBEPHX1 | |
| SCHEMBL19401615 | 0.89 | BTN3A1 (0.36) | BTN3A1MEN1KMT2AHSD17B10TDP1 | |
| SCHEMBL28094975 | 0.89 | THRB (0.48) | BTN3A1THRBEPHX1TSHR | |
| SCHEMBL28723526 | 0.89 | BTN3A1 (0.36) | BTN3A1THRBEPHX1 | |
| SCHEMBL28723557 | 0.89 | BTN3A1 (0.36) | BTN3A1THRBEPHX1 | |
| SCHEMBL10044435 | 0.89 | MEN1 (0.55) | BTN3A1MEN1KMT2ATHRBEPHX1 | |
| Ethylene Glycol SCHEMBL3391637 | 0.88 | TSHR (0.40) | BTN3A1MEN1KMT2AHSD17B10TDP1 | |
| SCHEMBL20327873 | 0.87 | ALDH1A1 (0.41) | BTN3A1MEN1KMT2AHSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2152771-B2 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON CATALYTIC CHEM IND (JP) | 2021-03-10 | — | — | EP | disclosed |
| EP-2152771-B1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON CATALYTIC CHEM IND (JP) | 2016-09-07 | — | — | EP | disclosed |
| US-8754264-B2 | Production method of unsaturated (poly)alkylene glycol ether monomer and production method of (poly)alkylene glycol chain-containing polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754264-B2 | Production method of unsaturated (poly)alkylene glycol ether monomer and production method of (poly)alkylene glycol chain-containing polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20100130793-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON SHOKUBAI CO. LTD (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20100130793-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | NIPPON SHOKUBAI CO. LTD (JP) | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130793-A1 | PRODUCTION METHOD OF UNSATURATED (POLY)ALKYLENE GLYCOL ETHER MONOMER AND PRODUCTION METHOD OF (POLY)ALKYLENE GLYCOL CHAIN-CONTAINING POLYMER | ALOX12, ALOX5, DECR2 | BTN3A1 4681/4885MEN1 2509/4885KMT2A 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.